Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Lifevantage Corporation (LXRX)

« Back to company index

LXRX Chatter Timeline

Stock Ticker for LXRX

Most Active Tweeters for LXRX

UserTweets
@AceAnalyst 4
@techNICKaltradr 2
@ZolmaxNews 2
@bulletin_en 2
@WKRBNews 1

Recent Tweets for LXRX

ez_alertz @ez_alertz
$LXRX Lexicon Pharmaceuticals to Present at Upcoming Investor Conference https://t.co/Jum6EnTIAI
May 23rd 2019, 7:05am
WeekHerald @WeekHerald
Lexicon Pharmaceuticals $LXRX Downgraded by BidaskClub https://t.co/bmPqVEICfZ
May 23rd 2019, 5:05am
dispatchtribune @dispatchtribune
Lexicon Pharmaceuticals $LXRX Lowered to Sell at ValuEngine https://t.co/HaJ0r4K97K
May 23rd 2019, 5:05am
AmericanBanking @AmericanBanking
Lexicon Pharmaceuticals, Inc. $LXRX Receives Average Rating of “Hold” from Brokerages https://t.co/AbtbeDT9bG #stocks
May 23rd 2019, 4:05am
WKRBNews @WKRBNews
Lexicon Pharmaceuticals, Inc. $LXRX Given Average Rating of “Hold” by Analysts https://t.co/DAs0VixMRg #markets
May 23rd 2019, 4:05am
FinZTribune @FinZTribune
How Many Lexicon Pharmaceuticals, Inc. $LXRX's Analysts Are Bearish? https://t.co/gNuZ93kZNp
May 22nd 2019, 7:05am
techNICKaltradr @techNICKaltradr
$LXRX following that trendline perfectly... just an updated chart nothing adjusted on my end. Nearing the bigger mo… https://t.co/xujBXGHC4K
May 21st 2019, 7:05pm
ZolmaxNews @ZolmaxNews
Lexicon Pharmaceuticals $LXRX Lowered to “Sell” at BidaskClub https://t.co/TTTac0qM92
May 21st 2019, 7:05am
OlympiaReport @OlympiaReport
Lexicon Pharmaceuticals $LXRX Cut to “Sell” at ValuEngine https://t.co/GY3zyn8f2L
May 21st 2019, 7:05am
ChartMill @ChartMill
$LXRX has a better Debt to Equity ratio than 98% of its industry peers. https://t.co/yigJGU4zM8 https://t.co/OcQzoycXqJ
May 20th 2019, 9:05am
AceAnalyst @AceAnalyst
$LXRX My viewpoint on the CRL issued by the FDA is that of something went wrong in the back end and has nothing to… https://t.co/GEgYtp6NYZ
May 19th 2019, 10:05pm
FlyOnTheWallHQ @FlyOnTheWallHQ
RT @StockWatchHQ: Lexicon Pharmaceuticals $LXRX Considering Acquisition Offer From Regeneron Pharmaceuticals $REGN, Talks In Tarrytown, NY…
May 19th 2019, 7:05pm
StockWatchHQ @StockWatchHQ
Lexicon Pharmaceuticals $LXRX Considering Acquisition Offer From Regeneron Pharmaceuticals $REGN, Talks In Tarrytow… https://t.co/iVdlW1asaW
May 18th 2019, 7:05pm
SwingTradeBot @SwingTradeBot
50 DMA Support today: $ACAD $LXRX ... https://t.co/aW7zteKP9U
May 16th 2019, 12:05pm
techNICKaltradr @techNICKaltradr
$LXRX cyclical timing wants a move here within the next few weeks. Look at the largest breakouts in each expansion… https://t.co/i8GRmeXr4e
May 16th 2019, 11:05am
AceAnalyst @AceAnalyst
$LXRX today’s conference was basically a leak of what’s to come. They basically told us the drug will get approved… https://t.co/NT9Rn62POt
May 16th 2019, 12:05am
bulletin_en @bulletin_en
Reviewing Wave Life Sciences Ltd. $LXRX's results https://t.co/vrcxFLiRIF
May 15th 2019, 5:05pm
AceAnalyst @AceAnalyst
$LXRX Presentation today should give us some hidden secrets we have been looking for! $35 PT
May 15th 2019, 2:05pm
WatchlistN @WatchlistN
Brokerages Expect Lexicon Pharmaceuticals, Inc. $LXRX Will Announce Quarterly Sales of $24.66 Million https://t.co/2SRVWUHYtR
May 14th 2019, 9:05pm
bulletin_en @bulletin_en
Halozyme Therapeutics Inc. $LXRX https://t.co/F8smqutau2
May 14th 2019, 9:05pm
AceAnalyst @AceAnalyst
$LXRX Cheap right now! Adding
May 13th 2019, 12:05pm
macondailynews @macondailynews
Lexicon Pharmaceuticals, Inc. $LXRX Expected to Announce Quarterly Sales of $24.66 Million https://t.co/hrO3HznUTD
May 12th 2019, 4:05pm
TickerReport @TickerReport
Lexicon Pharmaceuticals $LXRX Lifted to Hold at BidaskClub https://t.co/e9oFx3D8uO
May 11th 2019, 3:05am
ZolmaxNews @ZolmaxNews
Lexicon Pharmaceuticals $LXRX Lifted to Hold at BidaskClub https://t.co/Bz38WfLUYi
May 11th 2019, 3:05am
intercooleronli @intercooleronli
Lexicon Pharmaceuticals, Inc. $LXRX Expected to Announce Earnings of -$0.09 Per Share https://t.co/5vDYT2VfZV #investingnews
May 10th 2019, 1:05pm
ledgerzette @ledgerzette
Lexicon Pharmaceuticals, Inc. $LXRX Expected to Announce Earnings of -$0.09 Per Share https://t.co/gCNg3mCGsT #stocks
May 10th 2019, 1:05pm
stocknewstimes @stocknewstimes
Lexicon Pharmaceuticals $LXRX Upgraded at BidaskClub https://t.co/nRFXJhx65c
May 10th 2019, 12:05pm
SleekMoneycom @SleekMoneycom
Lexicon Pharmaceuticals $LXRX Upgraded at BidaskClub https://t.co/Od3YXc628d #investing
May 10th 2019, 12:05pm
dailypoliticaln @dailypoliticaln
Lexicon Pharmaceuticals $LXRX Lifted to Hold at BidaskClub https://t.co/Q8NuQgKdLo
May 9th 2019, 11:05am
ez_alertz @ez_alertz
$LXRX Lexicon Pharmaceuticals to Present at Upcoming Investor Conference https://t.co/QgmY3FU3Bc
May 8th 2019, 7:05am
FinZTribune @FinZTribune
Lexicon Pharmaceuticals $LXRX Shares Were Upgraded Today by BidaskScore https://t.co/2h2dy2n5N2
May 8th 2019, 12:05am
KanandaBarrons @KanandaBarrons
$LXRX #Bullish trend detected last 25th April, bouncing off my trendline! Consolidated 28% Profits since that date! https://t.co/TViOtVNGj7
May 7th 2019, 12:05pm
WeekHerald @WeekHerald
FY2019 EPS Estimates for Lexicon Pharmaceuticals, Inc. $LXRX Increased by Gabelli https://t.co/BNGbwLKFer
May 7th 2019, 3:05am
AmericanBanking @AmericanBanking
$24.71 Million in Sales Expected for Lexicon Pharmaceuticals, Inc. $LXRX This Quarter https://t.co/t5Pz8oTDq9 #stocks
May 7th 2019, 3:05am
ConsumerFeed @ConsumerFeed
Lexicon Pharmaceuticals $LXRX Stock Rating Upgraded by BidaskClub https://t.co/NstamnulOF
May 7th 2019, 1:05am
StockStalk3r @StockStalk3r
These are the plays I think to myself...”Self, why didn’t you buy more shares?” $LXRX
May 6th 2019, 10:05am
StockStalk3r @StockStalk3r
$LXRX Quietly killing it
May 6th 2019, 10:05am
StockStalk3r @StockStalk3r
$LXRX Moving Nicely
May 6th 2019, 9:05am
SelfThink4 @SelfThink4
$LXRX strong start early
May 6th 2019, 9:05am
dailypoliticaln @dailypoliticaln
Lexicon Pharmaceuticals $LXRX Stock Rating Reaffirmed by Needham & Company LLC https://t.co/CyEm6gGUGa
May 6th 2019, 4:05am
ZolmaxNews @ZolmaxNews
Lexicon Pharmaceuticals $LXRX Stock Rating Reaffirmed by Needham & Company LLC https://t.co/wpXhfGP6BF
May 6th 2019, 4:05am
TickerReport @TickerReport
Lexicon Pharmaceuticals, Inc. $LXRX Expected to Post FY2019 Earnings of -$0.65 Per Share https://t.co/U4kPLxxqjF
May 6th 2019, 3:05am
AmericanBanking @AmericanBanking
Wedbush Comments on Lexicon Pharmaceuticals, Inc.’s Q2 2019 Earnings $LXRX https://t.co/YdzM3mZZGv #stocks
May 6th 2019, 1:05am
dispatchtribune @dispatchtribune
Wedbush Comments on Lexicon Pharmaceuticals, Inc.’s Q2 2019 Earnings $LXRX https://t.co/H2Uah2XTZR
May 6th 2019, 1:05am
TheMarketsDaily @TheMarketsDaily
Lexicon Pharmaceuticals $LXRX Earns “Hold” Rating from Needham & Company LLC https://t.co/mjpAredlnR
May 6th 2019, 12:05am
StockNewsWires @StockNewsWires
$LXRX $SRI: Here’s What Hedge Funds Think About Lexicon Pharmaceuticals …: https://t.co/Ixt9GJQyM0
May 5th 2019, 8:05pm
ChartMill @ChartMill
A Current Ratio of 5.20 indicates that $LXRX has no problem at all paying its short term obligations.… https://t.co/IlVdo1Yxc2
May 5th 2019, 5:05pm
dailypoliticaln @dailypoliticaln
Lexicon Pharmaceuticals, Inc. $LXRX Expected to Post Earnings of -$0.09 Per Share https://t.co/cvr0H1bimM
May 5th 2019, 2:05pm
AmericanBanking @AmericanBanking
Analysts Expect Lexicon Pharmaceuticals, Inc. $LXRX Will Announce Earnings of -$0.09 Per Share https://t.co/dAxEZlW8Gc #stocks
May 5th 2019, 2:05pm
SelfThink4 @SelfThink4
$LXRX like this long. Has income generating assets and p2 data coming in second half of 2019.
May 4th 2019, 9:05am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.